BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

GRMOVER vs NATHBIOGEN: Stock Comparison

GRM OVERSEAS vs NATH BIO-GENES (I)Updated 20 Nov 26, 4:08 PM ISTNSE & company filings

GRM OVERSEAS is the larger company by market capitalisation. GRM OVERSEAS shows a higher ROE, faster revenue growth and a higher ROCE, while NATH BIO-GENES (I) shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRMOVER leads 7; NATHBIOGEN leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRMOVERNATHBIOGEN

Valuation lens

What price are you paying?

Market CapContext only
₹1,706 Cr
₹253 Cr
P/E RatioNATHBIOGEN has the lower reading
21.28x
8x ✓
P/B RatioNATHBIOGEN has the lower reading
2.66x
0.43x ✓
EPSGRMOVER has the higher reading
₹0.88 ✓
₹0.22
Book ValueContext only
₹29.22
₹358.06
Dividend YieldNATHBIOGEN has the higher reading
0%
1.5% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRMOVER is the larger company
₹1,706 Cr vs ₹253 Cr
P/E Ratio
NATHBIOGEN has a lower P/E
8x vs 21.28x
P/B Ratio
NATHBIOGEN has a lower P/B
0.43x vs 2.66x
EPS
GRMOVER has higher earnings per share
₹0.88 vs ₹0.22
Dividend Yield
NATHBIOGEN has a higher dividend yield
1.5% vs 0%
Revenue Growth (TTM YoY)
GRMOVER has faster revenue growth
105% vs -1%
EPS Growth (TTM YoY)
GRMOVER has faster EPS growth
137.8% vs 0%
Qtr Sales Growth
GRMOVER has stronger quarterly sales growth
6.13% vs -87.59%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRMOVERNATHBIOGEN
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryOther Agricultural ProductsOther Agricultural Products

Price

MetricGRMOVERNATHBIOGEN
Live Price₹82.36₹132.73
Day Change-0.4%-0.46%
Volume10.72 L2,217
52-Week High₹517.7₹204
52-Week Low₹77₹126.15
Distance from 52W High-84.09%-34.94%

Valuation

MetricGRMOVERNATHBIOGEN
Market Cap₹1,706 Cr₹253 Cr
P/E Ratio21.28x8x
P/B Ratio2.66x0.43x
EPS₹0.88₹0.22
Book Value₹29.22₹358.06
Dividend Yield0%1.5%

Growth

MetricGRMOVERNATHBIOGEN
Revenue Growth (TTM YoY)105%-1%
EPS Growth (TTM YoY)137.8%0%
Qtr Sales Growth6.13%-87.59%
Qtr Profit Growth-13.06%-98.7%

Profitability & Leverage

MetricGRMOVERNATHBIOGEN
ROE9.7%6.12%
ROCE7.48%-0.03%
Net Margin4.22%9.35%
Operating Margin8.09%14.46%
Debt to Equity0.67x0.2x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGRMOVERNATHBIOGEN
Promoter Holding63.06%45.6%
FII Holding6.34%▼ 0.94 pp0.19%▼ 0.08 pp
DII Holding2.91%0.01%
Public Holding27.69%▲ 0.94 pp54.21%▲ 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRM OVERSEAS and NATH BIO-GENES (I).

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.